Efficacy of Botulinum Toxin Type A in Improving Scar Quality and Wound Healing: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Botulinum toxin type A-induced "chemoimmobilization" has long been utilized for improved scar quality and wound healing; however, current evidence is limited to small-sized studies, and evidence-based information is inadequate for making well-informed decisions. The purpose of this study was to evaluate the efficacy of botulinum toxin type A (BTA) in improving scars and wound healing. Databases, including Pubmed, Embase, and Cochrane Library, were searched to identify randomized clinical trials that compared outcomes of surgical scars and wounds treated with BTA versus those treated with blank or placebo controls. The Visual Analog Scale (VAS), the Vancouver Scar Score (VSS), the width of the scar, and reported patient satisfaction were used in evaluating outcomes. Adverse events were also recorded. There were 11 RCTs involving a total of 486 cases (374 patients). Quantitative synthesis suggested that compared with the control group, patients in the BTA treatment group have significantly higher VAS scores [mean difference (MD)=1.30, 95% confidence interval (CI) 1.05 to 1.55], lower VSS scores [MD=-1.62, 95% CI: -2.49 to -0.75, P=0.0003], and thinner scars [MD=-0.15, 95% CI: -0.20 to -0.11, P<0.00001]. The patient satisfaction results show higher satisfaction in the BTA group over the control group [RR 1.25, 95% CI 1.06 to 1.49, P=0.01]. Trivial adverse events were reported. This meta-analysis of RCTs provides reliable evidence that BTA injection is superior to placebo or blank control group in improving scar quality and wound healing in the face and the neck for Asians, and negative outcomes for BTA treatment in these patients include only trivial adverse events. However, there is inadequate evidence presented in this paper to support the use of BTA in Caucasians for primary surgical scars or for scars in locations other than the face and neck. Further studies on the standardized injection regimen and technique of BTA are warranted for clinical practice.